Board Change • May 20
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Na Sun was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Tillkännagivande • Mar 31
Levima Advanced Materials Corporation to Report Q1, 2026 Results on Apr 23, 2026 Levima Advanced Materials Corporation announced that they will report Q1, 2026 results on Apr 23, 2026 Tillkännagivande • Mar 28
Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026 Levima Advanced Materials Corporation, Annual General Meeting, Apr 20, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China Tillkännagivande • Dec 31
Levima Advanced Materials Corporation to Report Fiscal Year 2025 Results on Mar 28, 2026 Levima Advanced Materials Corporation announced that they will report fiscal year 2025 results on Mar 28, 2026 Tillkännagivande • Sep 30
Levima Advanced Materials Corporation to Report Q3, 2025 Results on Oct 15, 2025 Levima Advanced Materials Corporation announced that they will report Q3, 2025 results on Oct 15, 2025 Tillkännagivande • Jul 02
Levima Advanced Materials Corporation to Report First Half, 2025 Results on Aug 16, 2025 Levima Advanced Materials Corporation announced that they will report first half, 2025 results on Aug 16, 2025 Tillkännagivande • Apr 23
Levima Advanced Materials Corporation Approves Cash Dividend on A Shares for the Year 2024, Payable on April 29, 2025 Levima Advanced Materials Corporation at its Annual General Meeting held on 18 April 2025, approved the Cash dividend (tax included) on A shares of CNY 0.60000000 per 10 shares for the year 2024. Record date is 28 April 2025. Ex-date is 29 April 2025. Payment date is 29 April 2025. Tillkännagivande • Mar 31
Levima Advanced Materials Corporation to Report Q1, 2025 Results on Apr 26, 2025 Levima Advanced Materials Corporation announced that they will report Q1, 2025 results on Apr 26, 2025 Tillkännagivande • Mar 29
Levima Advanced Materials Corporation Proposes Final Cash Dividend for the Year 2024 Levima Advanced Materials Corporation announced the profit distribution proposal for the year 2024 as final cash dividend (tax included) of CNY 0.60000000 per 10 shares. Tillkännagivande • Mar 28
Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025 Levima Advanced Materials Corporation, Annual General Meeting, Apr 18, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China Tillkännagivande • Dec 31
Levima Advanced Materials Corporation to Report Fiscal Year 2024 Results on Mar 28, 2025 Levima Advanced Materials Corporation announced that they will report fiscal year 2024 results on Mar 28, 2025 New Risk • Nov 14
New major risk - Revenue and earnings growth Earnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). Earnings have declined by 13% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.2% net profit margin). Reported Earnings • Oct 29
Third quarter 2024 earnings released: EPS: CN¥0.024 (vs CN¥0.059 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.024 (down from CN¥0.059 in 3Q 2023). Revenue: CN¥1.65b (down 4.4% from 3Q 2023). Net income: CN¥37.6m (down 52% from 3Q 2023). Profit margin: 2.3% (down from 4.5% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Tillkännagivande • Sep 30
Levima Advanced Materials Corporation to Report Q3, 2024 Results on Oct 26, 2024 Levima Advanced Materials Corporation announced that they will report Q3, 2024 results on Oct 26, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥14.77, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 24% over the past year. Board Change • Sep 03
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Na Sun was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 01
Second quarter 2024 earnings released: EPS: CN¥0.07 (vs CN¥0.13 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.07 (down from CN¥0.13 in 2Q 2023). Revenue: CN¥1.83b (up 12% from 2Q 2023). Net income: CN¥89.3m (down 50% from 2Q 2023). Profit margin: 4.9% (down from 11% in 2Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Tillkännagivande • Jun 29
Levima Advanced Materials Corporation to Report First Half, 2024 Results on Jul 27, 2024 Levima Advanced Materials Corporation announced that they will report first half, 2024 results on Jul 27, 2024 Reported Earnings • Apr 28
First quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.11 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.04 (down from CN¥0.11 in 1Q 2023). Revenue: CN¥1.49b (down 5.6% from 1Q 2023). Net income: CN¥51.4m (down 65% from 1Q 2023). Profit margin: 3.5% (down from 9.3% in 1Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Declared Dividend • Apr 20
Dividend reduced to CN¥0.08 Dividend of CN¥0.08 is 60% lower than last year. Ex-date: 25th April 2024 Payment date: 25th April 2024 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (24% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 36 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 85% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Tillkännagivande • Mar 30
Levima Advanced Materials Corporation to Report Q1, 2024 Results on Apr 27, 2024 Levima Advanced Materials Corporation announced that they will report Q1, 2024 results on Apr 27, 2024 Reported Earnings • Mar 29
Full year 2023 earnings released: EPS: CN¥0.33 (vs CN¥0.65 in FY 2022) Full year 2023 results: EPS: CN¥0.33 (down from CN¥0.65 in FY 2022). Revenue: CN¥6.78b (down 17% from FY 2022). Net income: CN¥446.1m (down 49% from FY 2022). Profit margin: 6.6% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Tillkännagivande • Mar 27
Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024 Levima Advanced Materials Corporation, Annual General Meeting, Apr 16, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China New Risk • Feb 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). High level of non-cash earnings (28% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.6% average weekly change). Profit margins are more than 30% lower than last year (7.4% net profit margin). Valuation Update With 7 Day Price Move • Jan 31
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥14.36, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 63% over the past year. Tillkännagivande • Dec 30
Levima Advanced Materials Corporation to Report Fiscal Year 2023 Results on Mar 27, 2024 Levima Advanced Materials Corporation announced that they will report fiscal year 2023 results on Mar 27, 2024 Reported Earnings • Oct 31
Third quarter 2023 earnings released: EPS: CN¥0.059 (vs CN¥0.24 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.059 (down from CN¥0.24 in 3Q 2022). Revenue: CN¥1.73b (down 30% from 3Q 2022). Net income: CN¥78.4m (down 76% from 3Q 2022). Profit margin: 4.5% (down from 13% in 3Q 2022). Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Tillkännagivande • Sep 30
Levima Advanced Materials Corporation to Report Q3, 2023 Results on Oct 26, 2023 Levima Advanced Materials Corporation announced that they will report Q3, 2023 results on Oct 26, 2023 New Risk • Jul 23
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 55% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Upcoming Dividend • Apr 28
Upcoming dividend of CN¥0.20 per share at 0.7% yield Eligible shareholders must have bought the stock before 05 May 2023. Payment date: 05 May 2023. Payout ratio is a comfortable 26% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of Chinese dividend payers (2.0%). Lower than average of industry peers (1.9%). Buying Opportunity • Mar 15
Now 20% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be CN¥38.68, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 20%. Revenue is forecast to grow by 49% in 2 years. Earnings is forecast to grow by 123% in the next 2 years. Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥35.24, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 8.0% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥39.00 per share. Board Change • Nov 16
High number of new and inexperienced directors There are 11 new directors who have joined the board in the last 3 years. The company's board is composed of: 11 new directors. No experienced directors. No highly experienced directors. Employee Representative Supervisor Jingjun Zhou is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Valuation Update With 7 Day Price Move • Nov 05
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥38.55, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 15x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥47.09 per share. Buying Opportunity • Oct 14
Now 25% undervalued after recent price drop Over the last 90 days, the stock is down 2.4%. The fair value is estimated to be CN¥52.35, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 47% in 2 years. Earnings is forecast to grow by 104% in the next 2 years. Buying Opportunity • Sep 16
Now 24% undervalued Over the last 90 days, the stock is up 23%. The fair value is estimated to be CN¥57.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 48% in 2 years. Earnings is forecast to grow by 110% in the next 2 years. Valuation Update With 7 Day Price Move • Sep 07
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥48.13, the stock trades at a forward P/E ratio of 45x. Average forward P/E is 17x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥58.50 per share. Buying Opportunity • Aug 31
Now 20% undervalued Over the last 90 days, the stock is up 72%. The fair value is estimated to be CN¥57.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last year. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 46% in 2 years. Earnings is forecast to grow by 83% in the next 2 years. Reported Earnings • Jul 29
Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.21 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.26 (up from CN¥0.21 in 2Q 2021). Revenue: CN¥2.38b (up 18% from 2Q 2021). Net income: CN¥349.4m (up 29% from 2Q 2021). Profit margin: 15% (up from 13% in 2Q 2021). Over the next year, revenue is forecast to grow 22%, compared to a 42% growth forecast for the industry in China. Valuation Update With 7 Day Price Move • Jul 19
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥40.50, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 17x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥57.37 per share. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment improved over the past week After last week's 24% share price gain to CN¥33.45, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 18x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥53.95 per share. Valuation Update With 7 Day Price Move • May 21
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥25.47, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 16x in the Chemicals industry in China. Reported Earnings • Apr 27
First quarter 2022 earnings released: EPS: CN¥0.08 (vs CN¥0.20 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.08 (down from CN¥0.20 in 1Q 2021). Revenue: CN¥1.56b (down 14% from 1Q 2021). Net income: CN¥107.4m (down 60% from 1Q 2021). Profit margin: 6.9% (down from 15% in 1Q 2021). Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China. Board Change • Apr 27
High number of new and inexperienced directors There are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. No highly experienced directors. Non-Employee Supervisor Rongguang Liu is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Apr 06
Full year 2021 earnings released: EPS: CN¥0.82 (vs CN¥0.56 in FY 2020) Full year 2021 results: EPS: CN¥0.82 (up from CN¥0.56 in FY 2020). Revenue: CN¥7.58b (up 28% from FY 2020). Net income: CN¥1.09b (up 70% from FY 2020). Profit margin: 14% (up from 11% in FY 2020). Over the next year, revenue is forecast to grow 21%, compared to a 48% growth forecast for the industry in China. Board Change • Dec 10
High number of new and inexperienced directors There are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 1 experienced director. No highly experienced directors. Non-Employee Supervisor Rongguang Liu is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.